Wyeth PFE
-
New Morningstar Analyst Report for Zoetis Inc.
… over the next five years. Zoetis has recently seen margin improvement due to synergies from the acquisitions of Fort Dodge ( Wyeth ) and Alpharma (King Pharma) and from Pfizer's companywide cost-reduction program. Management expects continued margin …
-
Pfizer's Prevnar 13: The World's Leading Vaccine And Its Competitors
By Peter Geschek : Prevnar 13 from Pfizer's ( PFE ) Wyeth division is an enormously successful pneumococcal conjugate vaccine, currently the best-selling vaccine in the world. Prevnar …
-
New Morningstar Analyst Report - ViroPharma, Inc.
… question after the drug failed to reduce the rate of CMV disease for transplant patients in a Phase III trial.ViroPharma and Wyeth (now a part of Pfizer) broke off their partnership for the development of a hepatitis C drug after a Phase II trial revealed …
-
New Morningstar Analyst Report - Pfizer
… faces significant integration risks with Wyeth . Flight of intellectual talent or failure ..... Cost-cutting efforts associated with the Wyeth merger could exceed our expectations ..... 22.5 billion in debt to finance the Wyeth acquisition, we believe its strong cash …
-
Pfizer's Period Of Slow Growth May Be Behind It
By Freedonia Freelance : In 2011, after its merger with Wyeth , Pfizer ( PFE ) became the world's largest pharmaceutical company ..... bandwagon and take over three major pharmaceutical contributors: Wyeth in 2011, Pharmacia Complete Story »
-
Pfizer (PFE) has agreed to pay $67.5M to settle a class-action lawsuit filed by former Wyeth shareholders who claimed they were misled about risks associated with the antidepressant Pristiq. The ...
Pfizer ( PFE ) has agreed to pay $67.5M to settle a class-action lawsuit filed by former Wyeth shareholders who claimed they were misled about risks associated with the antidepressant Pristiq. The all-cash settlement comes …
-
Pfizer to pay $67.5 million in investor lawsuit over Pristiq
NEW YORK (Reuters) - Pfizer Inc agreed to pay $67.5 million to settle a class-action lawsuit by former Wyeth Inc shareholders who said they were misled about risks associated with the antidepressant Pristiq.
-
Pfizer to pay $67.5 mln in investor lawsuit over Pristiq
* Wyeth said to have misled about antidepressant's risks * Wyeth 's market value lost more than $7.6 bln * Pfizer bought Wyeth in 2009; does not admit wrongdoing By Jonathan Stempel and...
-
Buy Pfizer With A 7.85% Discount Through Options
… Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition. Following the major acquisition of Wyeth , prescription drugs now account for close to 90% of sales. PFE's top sellers include cholesterol-lowering Lipitor, Celebrex …
-
Pfizer - Company Is Still Cleaning Up After Wyeth Mega-Merger
By Robert Broens : Shares of Pfizer ( PFE ) ended the week with losses of 3%. The global biopharmaceutical company postponed the release of its third quarter results to Wednesday as a result of the impact of hurricane Sandy. Third Quarter Results Pfizer rep orted third quarter revenues of $14.0 ...